Skip to main content

Table 1 Gene alterations in tumor samples

From: Genetic profiling of patients with adenoid cystic carcinoma of the Bartholin’s glands reveals potential new routes for targeted therapies: a case report

CaseGene alterationVAF (%)CNPathogenicity
1KRAS G12D12.42.20Pathogenic
2KDM6A c.2832 + 1G > C41.92.06Pathogenic
  1. VAF Variant allele frequency, CN Copy number.